StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO)

Stock analysts at StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued to investors on Saturday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

NASDAQ TTOO opened at $0.11 on Friday. T2 Biosystems has a 1-year low of $0.06 and a 1-year high of $6.80. The stock’s 50 day simple moving average is $0.12 and its 200-day simple moving average is $0.44.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.